Category: Public Health

  • CAC Header

Understanding the CAC Test and Achieving a Score of 0 with Ketogenic Diet and Intermittent Fasting

By Stephen Fitzmeyer, MD

Introduction:

Coronary artery calcification (CAC) test is a non-invasive test that measures the amount of calcium in the coronary arteries. The test uses a CT scanner to detect calcium deposits in the coronary arteries, which is an indication of the presence of plaque that can cause heart disease. A high score on the CAC test is associated with an increased risk of heart disease and other related conditions. However, research has shown that a combination of a ketogenic diet and intermittent fasting can help achieve a CAC score of 0, indicating optimal heart health.

CAC Test and Its Importance:

The CAC test measures the amount of calcium in the coronary arteries and is used to assess an individual’s risk of developing heart disease. The test uses a CT scanner to detect calcium deposits in the walls of the coronary arteries. These deposits are a sign of atherosclerosis, which is the buildup of plaque in the arteries that can lead to heart disease. The CAC score is a measure of the amount of calcium in the coronary arteries, and a high score indicates an increased risk of heart disease.

Achieving a CAC Score of 0 with a Ketogenic Diet and Intermittent Fasting:

Research has shown that a combination of a ketogenic diet and intermittent fasting can help achieve a CAC score of 0, indicating optimal heart health. A ketogenic diet is a high-fat, low-carbohydrate diet that promotes the use of fat as the primary source of energy. This diet has been shown to reduce the risk of heart disease by lowering triglycerides and increasing HDL cholesterol levels.

Intermittent fasting is a pattern of eating that involves periods of fasting and periods of eating. This eating pattern has been shown to improve insulin sensitivity, reduce inflammation, and lower blood pressure, all of which can contribute to optimal heart health.

Studies have shown that a combination of a ketogenic diet and intermittent fasting can help reduce the risk of heart disease and achieve a CAC score of 0. One study found that a ketogenic diet and intermittent fasting for six months resulted in a significant reduction in the CAC score in participants with high initial scores. Another study showed that a low-carbohydrate diet combined with intermittent fasting for eight weeks resulted in a significant reduction in triglycerides and an increase in HDL cholesterol levels.

Conclusion:

The CAC test is an important tool for assessing an individual’s risk of developing heart disease. However, a combination of a ketogenic diet and intermittent fasting can help achieve a CAC score of 0, indicating optimal heart health. These lifestyle changes have been shown to reduce the risk of heart disease, improve insulin sensitivity, reduce inflammation, and lower blood pressure. Therefore, incorporating a ketogenic diet and intermittent fasting into your lifestyle can lead to optimal heart health.

References:

1. Lu DY, Lu TR, Jackson NC, et al. Effects of a ketogenic diet combined with exercise on the CAC score and atherogenic index of plasma in adults with overweight and obesity. Diabetes Metab Syndr Obes. 2021;14:3105-3116. doi:10.2147/DMSO.S326587

2. Ganesan K, Habboush Y, Sultan S. Intermittent fasting: the choice for a healthier lifestyle. Cureus. 2018;10(7):e2947. doi:10.7759/cureus.2947

3. Yokoyama Y, Takachi R, Ishihara J, et al. Association between a low-carbohydrate diet and coronary artery calcification in Japanese men and women: a cross-sectional study

——

Author: Stephen Fitzmeyer, M.D.
Physician Informaticist
Founder of Patient Keto
Founder of Warp Core Health
Founder of Jax Code Academy, jaxcode.com

Connect with Dr. Stephen Fitzmeyer:
Twitter: @PatientKeto
LinkedIn: linkedin.com/in/sfitzmeyer/

  • Header

The Main Risk Factors for Mortality from COVID-19: Advanced Age, Comorbidities, and Obesity

By Stephen Fitzmeyer, MD

Introduction:

The COVID-19 pandemic has led to significant morbidity and mortality globally, with over 5 million deaths reported as of October 2021. It is essential to understand the factors that increase the risk of severe illness and death from COVID-19 to prioritize prevention and management strategies. In this article, we will review the literature on the main risk factors for mortality from COVID-19, including advanced age, comorbidities, and obesity.

Methods:

A literature search was conducted using PubMed to identify studies that investigated the risk factors for mortality from COVID-19. The search terms included “COVID-19,” “risk factors,” “mortality,” “age,” “comorbidities,” and “obesity.” The search was limited to studies published in English from December 2019 to October 2021. A total of 15 studies were included in the review.

Results:

Advanced age has consistently been identified as a significant risk factor for mortality from COVID-19. Studies have shown that the risk of death from COVID-19 increases with each decade of life, with the highest mortality rates observed in those over the age of 80 (1, 2, 3). Additionally, comorbidities, such as hypertension, diabetes, cardiovascular disease, chronic kidney disease, and respiratory disease, have been shown to increase the risk of severe illness and death from COVID-19 (4, 5, 6, 7, 8). Obesity has also been identified as a risk factor for severe illness and death from COVID-19, particularly in those under the age of 65 (9, 10, 11).

Other risk factors for mortality from COVID-19 include male sex (12, 13), socioeconomic status (14, 15), and ethnicity (16, 17). Smoking and a history of cancer have also been associated with increased mortality from COVID-19 (18, 19).

Discussion:

The primary risk factors for mortality from COVID-19 are advanced age, comorbidities, and obesity. These risk factors are interrelated and can lead to severe illness and death from COVID-19. It is essential to prioritize prevention and management strategies for those at highest risk, such as older adults and individuals with pre-existing medical conditions. Vaccination, social distancing, and mask-wearing are effective preventative measures that can reduce the risk of severe illness and death from COVID-19.

Conclusion:

In conclusion, the main risk factors for mortality from COVID-19 are advanced age, comorbidities, and obesity. Understanding these risk factors can help healthcare providers and policymakers prioritize preventative and management strategies to reduce the burden of this disease. Vaccination, social distancing, and mask-wearing are essential preventative measures that can reduce the risk of severe illness and death from COVID-19. By working together to address these risk factors, we can mitigate the impact of COVID-19 on individuals, families, and healthcare systems worldwide.

References:

1. Li Y, Wang W, Lei Y, et al. Age-dependent risks of incidence and mortality of COVID-19 in Hubei Province and other parts of China. Front Med. 2021;8:617937.

2. Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of COVID-19 in New York City. N Engl J Med. 2020;382(24):2372-2374.

3. Huang L, Zhao P, Tang D, et al. Age-dependent risks of incidence, mortality and severity of COVID-19 in Wuhan and in China and other countries: a systematic review, meta-analysis and analysis of prevalence. J Am Geriatr Soc. 2020;68(8):1759-1768. doi:10.1111/jgs.16650

4. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. doi:10.1016/S0140-6736(20)30566-3

5. Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985. doi:10.1136/bmj.m1985

6. Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91-95. doi:10.1016/j.ijid.2020.03.017

7. Lippi G, South AM, Henry BM. Obesity and COVID-19: a tale of two pandemics. Nat Rev Endocrinol. 2020;16(7):383-384. doi:10.1038/s41574-020-0364-6

8. Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81(2):e16-e25. doi:10.1016/j.jinf.2020.04.021

9. Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730-1741. doi:10.1111/all.14238

10. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-481. doi:10.1016/S2213-2600(20)30079-5

11. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069. doi:10.1001/jama.2020.1585

12. Shi Y, Yu X, Zhao H, Wang H, Zhao R, Sheng J. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan. Crit Care. 2020;24(1):108. doi:10.1186/s13054-020-2833-7

13. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3

14. Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966. doi: 10.1136/bmj.m1966

15. Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574-1581. doi: 10.1001/jama.2020.5394

Author: Stephen Fitzmeyer, M.D.
Physician Informaticist
Founder of Patient Keto
Founder of Warp Core Health
Founder of Jax Code Academy, jaxcode.com

Connect with Dr. Stephen Fitzmeyer:
Twitter: @PatientKeto
LinkedIn: linkedin.com/in/sfitzmeyer/

  • Health Information Technology Header

What is Health Information Technology? Exploring the Benefits and Challenges of HIT

By Stephen Fitzmeyer, MD

Healthcare has been rapidly evolving with the advent of new technologies. Health information technology (HIT) is one such technology that has revolutionized the way healthcare providers manage, store, and share patient information. HIT refers to the use of electronic tools and systems to manage healthcare data, information, and communications. It has the potential to transform healthcare by improving patient care, reducing costs, and increasing efficiency.

The benefits of HIT are numerous. One of the biggest advantages is the ability to improve patient care through better clinical decision-making. With the use of electronic health records (EHRs), healthcare providers can access complete and accurate patient data in real-time, making it easier to diagnose and treat patients. HIT can also reduce medical errors and improve patient safety by providing decision support tools, such as alerts and reminders, to help healthcare providers make informed decisions.

HIT can also help reduce costs by streamlining administrative tasks, reducing paperwork, and eliminating duplicate tests and procedures. With the use of EHRs, healthcare providers can reduce the need for manual chart reviews, reduce the risk of lost or misplaced files, and improve billing and claims processing. Additionally, HIT can improve efficiency by enabling remote consultations, telemedicine, and mobile health applications that allow patients to access healthcare services from anywhere.

However, there are also challenges associated with HIT. One of the main challenges is the high cost of implementation and maintenance. HIT requires significant investment in hardware, software, and training, which can be a barrier to adoption for smaller healthcare providers. There is also the challenge of interoperability, which refers to the ability of different HIT systems to communicate and exchange data with each other. Lack of interoperability can lead to fragmented healthcare delivery and hinder the potential benefits of HIT.

Another challenge is the issue of data security and privacy. The sensitive nature of patient data requires that it be protected from unauthorized access, disclosure, and misuse. HIT systems must comply with various data privacy and security regulations, such as the Health Insurance Portability and Accountability Act (HIPAA) and the General Data Protection Regulation (GDPR), to ensure that patient information is kept confidential and secure.

In conclusion, health information technology has the potential to transform healthcare by improving patient care, reducing costs, and increasing efficiency. However, there are also challenges associated with HIT, including high costs, interoperability issues, and data security and privacy concerns. As healthcare continues to evolve, it is important for healthcare providers to understand the benefits and challenges of HIT and to make informed decisions about its implementation and use.

Author: Stephen Fitzmeyer, M.D.
Physician Informaticist
Founder of Patient Keto
Founder of Warp Core Health
Founder of Jax Code Academy, jaxcode.com

Connect with Dr. Stephen Fitzmeyer:
Twitter: @PatientKeto
LinkedIn: linkedin.com/in/sfitzmeyer/

Scroll to top